Mr. Ros is a 30-year veteran of the biotechnology industry. Prior to joining Fore, he was the Executive Vice President and Chief Strategy and Business Officer of Epizyme, Inc., a commercial-stage and publicly traded biopharmaceutical company developing novel epigenetic therapies. He has experience building and leading teams across sales, marketing, franchise strategy and business operations. Prior to joining Epizyme, Mr. Ros served as Chief Operating Officer and Global Head of the Oncology Business Unit at Sanofi-Genzyme and held leadership positions at ARIAD Pharmaceuticals. Mr. Ros began his career at Bristol Myers Squibb, where he held positions of increasing responsibility in its Oncology division, contributing to the successful launches of many leading cancer therapies.
